NOT CURRENTLY APPROVED
Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation that is not reversible. An estimated 15 million people in the U.S. 18 and older have been diagnosed with COPD. Another estimated 12 million may have COPD that has not yet been diagnosed. The airflow limitation is usually progressive and associated with an abnormal inflammatory response in the airways and lungs to noxious particles or gases. The evidence-based GOLD guidelines, updated in December 2015, provide strategies for healthcare providers worldwide to prevent, diagnose, and manage COPD. This module provides clinicians with information about the incidence, causes, and symptoms of COPD and latest clinical guidelines.
The goal of this program is to provide nurses and respiratory therapists with information about the incidence, causes, and symptoms of chronic obstructive pulmonary disease. After studying the information presented here, you will be able to:
- Define COPD and identify its most common causes
- List three classes of medications for COPD
- Discuss four areas in which education can benefit patients with COPD
This CE course is approved for respiratory therapists.
This program has been approved for 1 contact hour of Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd., Suite 100, Irving, TX 75063. AARC Sponsor ID: 9514012. This is a non-traditional course. The course has been approved from 7/15/2009 to 1/1/2014 and 6/25/2014 to 6/25/2016.
If you are a respiratory therapist, remember to give us your AARC member number when filling out your license number information.
OnCourse Learning is also approved by the Florida Board of Respiratory Care (provider #FBN 50-1489).
Course Originally Released on:
Date of Most Recent Review:
Course Termination/Update Date:
Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. OnCourse Learning guarantees this educational activity is free from bias. There is no commercial or in-kind support provided for this online educational activity.
Please see CE Course Instructions to learn how to earn CE credit for this module. For successful completion of this course, learners must read the course, and complete a posttest and evaluation survey.
This CE activity does not include any unannounced information about off-label use of a product for a purpose other than that for which is approved by the Food and Drug Administration (FDA).
The approval status for this educational activity, granted by the AARC, does not expressly or implicitly confer AARC endorsement of the activity’s content.
This course completion will be electronically reported to CE Broker as required per Florida Statute 456.025(7). Click here to view your CE Broker transcript and check the status of your CE requirements with a FREE 7-day CE Broker trial subscription. It may take up to 24 hours for the course to appear on your CE Broker transcript.